001     861681
005     20210130000936.0
024 7 _ |a 10.1055/a-0807-8137
|2 doi
024 7 _ |a 0029-5566
|2 ISSN
024 7 _ |a 2567-6407
|2 ISSN
024 7 _ |a pmid:30769368
|2 pmid
024 7 _ |a WOS:000459505900001
|2 WOS
037 _ _ |a FZJ-2019-02118
082 _ _ |a 610
100 1 _ |a Tatsch, Klaus
|0 P:(DE-HGF)0
|b 0
|e Corresponding author
245 _ _ |a SPECT-Untersuchungen mit dem 123I-markierten Dopamintransporter-Liganden FP-CIT (DaTSCANTM)
260 _ _ |a Stuttgart
|c 2019
|b Thieme
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1553883005_25990
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a The aim of the S1 guideline is to assist in establishing the indication and in performing, interpreting and reporting SPECT investigations of the dopamine transporter (DAT) with DaTSCANTM. Compared to the preceding version dated from 2007 the current update considers relevant new publications, the guidelines of the European (EANM) and Society of Nuclear Medicine (SNM), and the current version of the S3 guideline of the German Society of Neurology on „Idiopathic Parkinsonsian Syndrome“. In addition new technical developments are incorporated.
536 _ _ |a 573 - Neuroimaging (POF3-573)
|0 G:(DE-HGF)POF3-573
|c POF3-573
|f POF III
|x 0
588 _ _ |a Dataset connected to CrossRef
700 1 _ |a Buchert, Ralph
|b 1
700 1 _ |a Bartenstein, Peter
|b 2
700 1 _ |a Barthel, Henryk
|b 3
700 1 _ |a Boecker, Henning
|b 4
700 1 _ |a Brust, Peter
|b 5
700 1 _ |a Drzezga, Alexander
|0 P:(DE-Juel1)177611
|b 6
|u fzj
700 1 _ |a la Fougère, Christian
|b 7
700 1 _ |a Gründer, Gerhard
|b 8
700 1 _ |a Grünwald, Frank
|b 9
700 1 _ |a Krause, Bernd-J.
|b 10
700 1 _ |a Kuwert, Torsten
|b 11
700 1 _ |a Langen, Karl-Josef
|0 P:(DE-Juel1)131777
|b 12
|u fzj
700 1 _ |a Rominger, Axel
|b 13
700 1 _ |a Sabri, Osama
|b 14
700 1 _ |a Schreckenberger, Mathias
|b 15
700 1 _ |a Meyer, Philipp T.
|b 16
773 _ _ |a 10.1055/a-0807-8137
|g Vol. 58, no. 01, p. 5 - 16
|0 PERI:(DE-600)2030804-8
|n 01
|p 5 - 16
|t Nuklearmedizin
|v 58
|y 2019
|x 2567-6407
909 C O |o oai:juser.fz-juelich.de:861681
|p VDB
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 6
|6 P:(DE-Juel1)177611
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 12
|6 P:(DE-Juel1)131777
913 1 _ |a DE-HGF
|b Key Technologies
|l Decoding the Human Brain
|1 G:(DE-HGF)POF3-570
|0 G:(DE-HGF)POF3-573
|2 G:(DE-HGF)POF3-500
|v Neuroimaging
|x 0
|4 G:(DE-HGF)POF
|3 G:(DE-HGF)POF3
914 1 _ |y 2019
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b NUKLEARMED-NUCL MED : 2017
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
915 _ _ |a WoS
|0 StatID:(DE-HGF)0110
|2 StatID
|b Science Citation Index
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
920 1 _ |0 I:(DE-Juel1)INM-2-20090406
|k INM-2
|l Molekulare Organisation des Gehirns
|x 0
920 1 _ |0 I:(DE-Juel1)INM-4-20090406
|k INM-4
|l Physik der Medizinischen Bildgebung
|x 1
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-Juel1)INM-2-20090406
980 _ _ |a I:(DE-Juel1)INM-4-20090406
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21